Unilateral retinoblastoma--genetic implications.
نویسندگان
چکیده
منابع مشابه
Chemoreduction for unilateral retinoblastoma.
OBJECTIVE To evaluate conservative management of unilateral retinoblastoma using chemoreduction and focal treatment. DESIGN Prospective nonrandomized single-center clinical trial. SETTING Ocular Oncology Service at Wills Eye Hospital of Thomas Jefferson University, Philadelphia, Pa, in conjunction with the Division of Oncology at The Children's Hospital of Philadelphia. PARTICIPANTS Thirt...
متن کامل2152 Conservative therapy of unilateral retinoblastoma
Methods: From lYYO-1993, 38 cases of unilutcrdl retinoblastoma were treated in National Cancer Center Hospital in Tokyo. Except for Y eyes with absolute glaucoma, suspicious extraocular extension or refusal of conservative therapy, all of them were treated conservatively. Ocular hypcrthetmia using Lagendijk’s applicator wwc combined with radiotherapy, selective t,, ophthalmic aaerial injection ...
متن کامل4231 Conservative therapy of unilateral retinoblastoma
Methods: From lYYO-lYY3,38 cases of unilateral retinoblastoma were treated in National Cancer Center Hospital in Tokyo. Except for 9 eyes with absolute glaucoma, suspicious extraocular extension or refusal of conservative therapy, all of them were treated conservatively. Ocular hyperthennia using Legendijk’s applicator were combined with radiotherapy, selective ophthalmic arterial injection by ...
متن کاملTrilateral retinoblastoma with unilateral eye involvement.
Trilateral retinoblastoma (TRb) is a rare combination of unilateral or bilateral retinoblastoma with an ectopic midline intracranial neuroblastic neoplasm (primitive neuroectodermal tumour) usually in the area of pineal gland or sellar region. TRb can occur with both familial and sporadic forms of retinoblastoma. An occurrence of this rare tumour in a 12-year-old boy who had unilateral retinobl...
متن کاملUnilateral retinoblastoma: new intraocular tumours after treatment.
A retrospective chart review of 427 eyes diagnosed with unilateral retinoblastoma was performed to determine which eyes, which patients, and when new intraocular tumours would develop after treatment. Mean follow up was 8.16 years. Twenty five (6%) of 427 unilateral retinoblastoma patients developed new intraocular tumours after treatment. Five (1%) unilateral patients who were previously treat...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: British Journal of Ophthalmology
سال: 1996
ISSN: 0007-1161
DOI: 10.1136/bjo.80.3.193